N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine

CAS: 152460-10-1

Ref. 3D-FA15934

Información del producto

• Nombre: N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine
• Sinónimos: 4-Methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]aniline4-Methyl-N'-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamineN-(5-Amino-o-to lyl)-4-(3-pyridyl)-2-pyrimidinamine, 1,3-Benzenediamine 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-, 1,3-Benzenediamine, 4-methyl-N³-[4-(3-pyridinyl)-2-pyrimidinyl]-, 2-(5-Amino-2-methylanilino)-4-(3-pyridyl)pyrimidine, 4-Methyl-3-[4-(3-pyridinyl)pyrimidin-2-ylamino]aniline, 4-Methyl-N'-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine, 4-Methyl-N3-[4-(3-pyridinyl)-2-pyrimidin-yl]-1,3-benzenediamine, 4-Methyl-N³-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-benzenediamine, 4-Methyl-N³-[4-(pyridin-3-yl)pyrimidin-2-yl]-1,3-benzenediamine, 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-Benzenediamine, 4-methyl-N~3~-(4-pyridin-3-ylpyrimidin-2-yl)benzene-1,3-diamine, 6-methyl-N'-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine, N-(2-Methyl-5-Amino Phenyl)-4-(3-Pyridyl)-2-Pyrimidine, N-(2-Methyl-5-aminophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine, N-(2-methyl-5-aminophenyl)-4-(3-pyridyl)-2-pyrimidine amine, N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)pyrimidin-2-amine, N-(5-Amino-2-methylphenyl)-4-(pyridin-3-yl)pyrimidin-2-ylamine, N-(5-Amino-2-methylphenyl)-6-(pyridin-3-yl)-2-pyrimidinamine, N-(5-Amino-2-methylphenyl)-N-[4-(3-pyridyl)pyrimidin-2-yl]amine, N-(5-Amino-2-methylphenyl)[4-(3-pyridyl)-2-pyrimidinyl]amine, N-(5-amino-2-methylphenl)-4-(3-pyridyl)-2-pyrimidine-amine, N-(5-amino-2-methylphenyl)-4-(3-pyrdyl)-2-pydimidineamine, N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine

Descripción

Imatinib is an anticancer drug that belongs to the class of trimethyls. It is a potent inhibitor of tyrosine-specific protein kinases, including Bcr-Abl and Src family kinases. It has been shown to have antineoplastic properties in human cells in vitro. Imatinib is structurally similar to the anticancer agent lapatinib and inhibits G1 phase cell cycle progression by preventing phosphorylation of retinoblastoma protein (Rb). Imatinib is also genotoxic due to its structural similarity to other known genotoxic compounds such as bromo-2′-deoxyuridine and 2-chloroimidazole.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 277.32 g/mol
• Fórmula: C₁₆H₁₅N₅
• Pureza: Min. 95%
• Color/Forma: Powder
• InChI: InChI=1S/C16H15N5/c1-11-4-5-13(17)9-15(11)21-16-19-8-6-14(20-16)12-3-2-7-18-10-12/h2-10H,17H2,1H3,(H,19,20,21)
• Clave InChI: InChIKey=QGAIPGVQJVGBIA-UHFFFAOYSA-N
• SMILES: Cc1ccc(N)cc1Nc1nccc(-c2cccnc2)n1